Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Immunochina Medical Science & Technology Co., Ltd.

Clinical trials sponsored by Beijing Immunochina Medical Science & Technology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New cell therapy trial targets Hard-to-Treat stomach cancers Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New cell therapy trial targets Hard-to-Treat stomach cancers

Disease control Not yet recruiting

This early-stage study tests a new treatment called IM96 CAR-T for people with advanced stomach or esophageal cancer that hasn't responded to standard therapies. The treatment uses a patient's own immune cells, modified to better attack cancer cells. The main goal is to check saf…

Phase 1 • Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC